Table 2 Patient Demographics and Clinical Characteristics
| Â | Number of patients (%) |
|---|---|
Total | 12 (100.0) |
Median age in years (range) | 62 (53–67) |
Sex | |
 Male | 8 (67.0) |
 Female | 4 (33.0) |
ECOG performance status | |
 0 | 0 (0) |
 1 | 12 (100.0) |
Tumor stage at the time of diagnosis | |
 I | 0 (0) |
 II | 1 (8.3) |
 III | 3 (25.0) |
 IV | 8 (66.7) |
Tumor stage at the time of enrolled | |
 Locally advanced PDAC | 3 (25.0) |
 Metastatic PDAC | 9 (75.0) |
Metastasis site | |
 Liver metastasis | 5 (55.5) |
 Lung metastasis | 1 (8.3) |
 Peritoneal metastasis | 2 (22.2) |
 Others | 1 (8.3) |
Prior chemotherapy therapy | |
 Yes | 9 (75.0) |
 No | 3 (25.0) |